Skip to main content
TNGX
NASDAQ Life Sciences

Tango Therapeutics Posts $68.4M Q3 Loss as Pipeline Costs Mount

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$21.82
Mkt Cap
$3.625B
52W Low
$7.37
52W High
$34.39
52W Position info
196% above low
Off High info
37% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

TNGX has more than doubled off its 52-week low of $7.37.

Summary

Tango Therapeutics reported a $68.4M loss for the third quarter, or 39 cents a share, wider than the $55.3M loss it posted in Q2, with revenue dropping to zero on the end of its Gilead deal. The company ended the third quarter with $977.5M in cash, down from the $1.0B it held at the end of Q2 after a June equity raise, and it has a $400M at-the-market program in place, so the loss is not a near-term liquidity problem — but the burn is climbing while the clinical story carries the valuation. The quarter follows the October 23 disclosure of an 82% overall response rate in 22 heavily pretreated MTAP-deleted/RAS-mutant pancreatic cancer patients for vopimetostat plus daraxonrasib, and a strategic reprioritization that cut roughly 14% of the workforce.

At the time of this announcement, TNGX was trading at $21.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $7.37 to $34.39. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

TNGX - Latest Insights

TNGX
Oct 23, 2026, 7:01 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $29.13
Real-time Price: $21.91 info
Change: -$7.22 (-25%) info
Market Cap: $3.625B info
TNGX
Oct 23, 2026, 6:36 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.85
Real-time Price: $21.91 info
Change: -$9.94 (-31%) info
Market Cap: $3.625B info
TNGX
Oct 23, 2026, 6:30 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $32.06
Real-time Price: $21.91 info
Change: -$10.15 (-32%) info
Market Cap: $3.625B info
TNGX
Aug 11, 2026, 5:10 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $26.45
Real-time Price: $21.91 info
Change: -$4.54 (-17%) info
Market Cap: $3.625B info
TNGX
Aug 11, 2026, 7:20 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.05
Real-time Price: $21.91 info
Change: -$6.14 (-22%) info
Market Cap: $3.625B info